Search research articles
Contact Us
Filters
Showing results (1-10 of 189) with videos related to
Page
of 19
Sort By:
Expert Opinion on Investigational Drugs
|
August 11, 2012
Lapatinib and renal cell carcinoma
Marine Gross-Goupil, Jean-Christophe Bernhard, Alain Ravaud
Minerva Urology and Nephrology
|
October 23, 2025
Comment on: "DCOM: a 3D virtual imaging-based nephrometry scoring system for robot-assisted partial nephrectomy"
Paolo Conforti, Gaëlle Margue, Jean-Christophe Bernhard, et al.
Archivos Espanoles De Urologia
|
November 25, 2010
Tyrosine-kinase inhibitors in the treatment of muscle invasive bladder cancer and hormone refractory prostate cancer
Hervé Wallerand, Grégoire Robert, Jean-Christophe Bernhard, et al.
3D Printing in Medicine
|
October 14, 2025
Using 3D-printing technology for patient education: a review of the literature
Sarah Masanet, Marthe-Aline Jutand, Gaëlle Margue, et al.
Targeted Oncology
|
January 4, 2013
Prolonged efficacy of mTOR inhibitors in papillary renal cell carcinoma: progression-free survival lasting for over 3 years, a case report and review of the literature
Amaury Daste, Marine Gross-Goupil, Sophie Roca, et al.
AJR. American Journal of Roentgenology
|
December 14, 2016
Is Multiparametric MRI Useful for Differentiating Oncocytomas From Chromophobe Renal Cell Carcinomas?
Chloe Galmiche, Jean-Christophe Bernhard, Mokrane Yacoub, et al.
Histopathology
|
October 27, 2021
Thyroid-like follicular renal cell carcinoma with sarcomatoid differentiation and an aggressive clinical course: a case report confirming the presence of the EWSR1::PATZ1 fusion gene
Raul Perret, Felix Lefort, Jean-Christophe Bernhard, et al.
Future Oncology (London, England)
|
June 14, 2017
Pulmonary arterial hypertension due to an intratumoral shunt: an unexpected side effect of sunitinib
Amaury Daste, Marion Laine, Marine Gross-Goupil, et al.
Journal of Surgical Case Reports
|
December 15, 2022
Feasibility of robotic-assisted partial nephrectomy for complete remission of metastatic renal cell carcinoma after long exposure to immune checkpoint inhibitors (UroCCR-106)
Samy Mebroukine, Mokrane Yacoub, Clément Michiels, et al.
Therapeutics and Clinical Risk Management
|
June 9, 2022
An Evaluation of Cabozantinib for the Treatment of Renal Cell Carcinoma: Focus on Patient Selection and Perspectives
Romain Iaxx, Felix Lefort, Charlotte Domblides, et al.
Page
of 19
Search research articles
Search
Showing results (1-10 of 189) with videos related to
Sort By:
Page
of 19
Expert Opinion on Investigational Drugs
|
August 11, 2012
Lapatinib and renal cell carcinoma
Marine Gross-Goupil, Jean-Christophe Bernhard, Alain Ravaud
Minerva Urology and Nephrology
|
October 23, 2025
Comment on: "DCOM: a 3D virtual imaging-based nephrometry scoring system for robot-assisted partial nephrectomy"
Paolo Conforti, Gaëlle Margue, Jean-Christophe Bernhard, et al.
Archivos Espanoles De Urologia
|
November 25, 2010
Tyrosine-kinase inhibitors in the treatment of muscle invasive bladder cancer and hormone refractory prostate cancer
Hervé Wallerand, Grégoire Robert, Jean-Christophe Bernhard, et al.
3D Printing in Medicine
|
October 14, 2025
Using 3D-printing technology for patient education: a review of the literature
Sarah Masanet, Marthe-Aline Jutand, Gaëlle Margue, et al.
Targeted Oncology
|
January 4, 2013
Prolonged efficacy of mTOR inhibitors in papillary renal cell carcinoma: progression-free survival lasting for over 3 years, a case report and review of the literature
Amaury Daste, Marine Gross-Goupil, Sophie Roca, et al.
AJR. American Journal of Roentgenology
|
December 14, 2016
Is Multiparametric MRI Useful for Differentiating Oncocytomas From Chromophobe Renal Cell Carcinomas?
Chloe Galmiche, Jean-Christophe Bernhard, Mokrane Yacoub, et al.
Histopathology
|
October 27, 2021
Thyroid-like follicular renal cell carcinoma with sarcomatoid differentiation and an aggressive clinical course: a case report confirming the presence of the EWSR1::PATZ1 fusion gene
Raul Perret, Felix Lefort, Jean-Christophe Bernhard, et al.
Future Oncology (London, England)
|
June 14, 2017
Pulmonary arterial hypertension due to an intratumoral shunt: an unexpected side effect of sunitinib
Amaury Daste, Marion Laine, Marine Gross-Goupil, et al.
Journal of Surgical Case Reports
|
December 15, 2022
Feasibility of robotic-assisted partial nephrectomy for complete remission of metastatic renal cell carcinoma after long exposure to immune checkpoint inhibitors (UroCCR-106)
Samy Mebroukine, Mokrane Yacoub, Clément Michiels, et al.
Therapeutics and Clinical Risk Management
|
June 9, 2022
An Evaluation of Cabozantinib for the Treatment of Renal Cell Carcinoma: Focus on Patient Selection and Perspectives
Romain Iaxx, Felix Lefort, Charlotte Domblides, et al.
Page
of 19